搜索临床试验以:123-I-MIP-1095
总计202个结果
-
Assistance Publique - Hôpitaux de ParisAssociation Française contre les Myopathies (AFM), Paris; ARS (Association pour la Recherche... 和其他合作者完全的
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.完全的
-
VA Puget Sound Health Care SystemDr. Gregory Merrick; Theragenics Corporation未知
-
Molecular Insight Pharmaceuticals, Inc.National Cancer Institute (NCI)撤销
-
Alseres Pharmaceuticals, Inc未知
-
Institute for Neurodegenerative DisordersMolecular NeuroImaging完全的
-
Institute for Neurodegenerative DisordersMolecular NeuroImaging完全的
-
Asan Medical Center终止
-
Progenics Pharmaceuticals, Inc.主动,不招人去势抵抗性前列腺癌 | 转移性前列腺癌 | 前列腺癌 | 前列腺肿瘤 | 进行性 mCRPC美国, 加拿大
-
University of WuerzburgDeutsche Krebshilfe e.V., Bonn (Germany)招聘中
-
GE HealthcareQuintiles, Inc.; H2O Clinical LLC完全的
-
Institute for Neurodegenerative DisordersMolecular NeuroImaging终止
-
University Hospital, Caen完全的
-
Memorial Sloan Kettering Cancer CenterGustave Roussy, Cancer Campus, Grand Paris主动,不招人
-
Peter MacCallum Cancer Centre, Australia招聘中
-
ModernaTX, Inc.完全的流感 | SARS-CoV-2 | 呼吸道合胞病毒英国, 澳大利亚, 美国
-
GE HealthcareABX CRO; H2O Clinical LLC; TransPerfect; Advanced Clinical, LLC; TFS; AG Mednet Inc.; ICON CEAC; ICON Clinical终止心脏衰竭美国, 西班牙, 加拿大, 法国, 荷兰, 波兰, 捷克语, 意大利, 德国, 匈牙利
-
Tomsk National Research Medical Center of the Russian...招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)完全的
-
Jena University HospitalGE Healthcare未知
-
New Approaches to Brain Tumor Therapy ConsortiumNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人复发性甲状腺癌 | 低分化甲状腺癌 | 难治性甲状腺癌 | IV 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺乳头状癌 AJCC v7 | IVA 期甲状腺滤泡性癌 AJCC v7 | IVA 期甲状腺乳头状癌 AJCC v7 | IVB 期甲状腺滤泡性癌 AJCC v7 | IVB 期甲状腺乳头状癌 AJCC v7 | IVC 期甲状腺滤泡性癌 AJCC v7 | IVC 期甲状腺乳头状癌 AJCC v7 | 转移性甲状腺癌美国